Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Research|August 28, 2003
Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumorsBryan M Wittmann, Nancy Wang, Monica M Montano
Cancer Research|October 3, 2007
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulatorsBryan M Wittmann, Andrea Sherk, Donald P McDonnell
Oncogene|June 9, 2005
The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1Bryan M Wittmann, Koh Fujinaga, Huayun Deng, et al.
The Biochemical Journal|May 22, 2014
HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgensI-Ju Yeh, Kyung Song, Bryan M Wittmann, et al.
Frontiers in Bioscience : a Journal and Virtual Library|March 17, 2005
Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifenMonica M Montano, Nicole R Bianco, Huayun Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Inhibition of prostate cancer cell growth by second-site androgen receptor antagonistsJames D Joseph, Bryan M Wittmann, Mary A Dwyer, et al.
Molecular Endocrinology (Baltimore, Md.)|October 29, 2010
Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancerSakiko Kobayashi, James P Stice, Dmitri Kazmin, et al.
Molecular Cell|November 18, 2009
The homeodomain protein HOXB13 regulates the cellular response to androgensJohn D Norris, Ching-Yi Chang, Bryan M Wittmann, et al.
Molecular Endocrinology (Baltimore, Md.)|November 11, 2009
Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulatorsCarolyn D DuSell, Erik R Nelson, Bryan M Wittmann, et al.
Journal of Mass Spectrometry : JMS|September 23, 2018
Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testingAdam D Kennedy, Bryan M Wittmann, Anne M Evans, et al.
Pageof 2